Agave 201 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agave 201. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agave 201 Today - Breaking & Trending Today

Emerging Agents in GVHD: Axatilimab

Published: February 22, 2024

The panel reviews axatilimab, an emerging agent for chronic GVHD under clinical studies. The experts explore findings from the Agave-201 study, highlighting potential challenges of intravenous administration and axatilimab’s unique mechanisms.

Source: onclive.com

Related Topics:

Dana Farber Cancer InstituteUnited StatesCorey CutlerHannah ChoeMitchell HorwitzBin ChenOhio State UniversityMarrow Transplant Program At Duke UniversityProfessor Of Medicine At Harvard Medical SchoolCell Therapy Program At MassachusettsCell Therapy ProgramMassachusetts General HospitalHarvard Medical SchoolStem Cell Transplant ProgramAdult BloodMarrow Transplant ProgramDuke UniversityAssistant ProfessorOhio StateChronic Graft Versus Host DiseaseCsf 1r InhibitorIv InfusionAgave 201Ast Alt LevelsCombination Therapy